Carlsmed legal chief holds 56,222 common shares

Her RSUs vest in three equal annual installments beginning on the first anniversary of the grant date, subject to continued service.

Rhea-AI Filing Summary

Carlsmed, Inc. (CARL) reports that Chief Legal Officer Jennifer Kamocsay directly held 56,222 common shares and stock options covering 90,000 common shares as of September 24, 2026. The options have a $13.45 exercise price and expire September 28, 2035. Twenty-five percent vested on September 29, 2025; the remaining 75% vest in quarterly 1/12 installments, subject to continued service.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Kamocsay Jennifer

Role Chief Legal Officer

Type	Security	Shares	Price	Value
holding	Stock Option (Right to Buy) F2	--	--	--
holding	Common Stock F1	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 90,000 contracts (Direct); Common Stock — 56,222 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date, January 28, 2026, subject to the Reporting Person's continued service through each such vesting date.
2. F2. Includes 90,000 vested and unvested stock options convertible into approximately 90,000 shares of the Issuer's Common Stock. 25% of the stock options vested upon the one year anniversary of the grant date, September 29, 2025, and the remaining 75% of the stock options will vest in 1/12th installments on a quarterly basis thereafter, subject to the Reporting Person's continued service through each such vesting date.

Key Figures

Direct common shares: 56,222 shares Option underlying shares: 90,000 shares Option exercise price: $13.45 per share +3 more

6 metrics

Direct common shares 56,222 shares Reported as of September 24, 2026

Option underlying shares 90,000 shares Direct stock option position reported as of September 24, 2026

Option exercise price $13.45 per share Stock options

Option expiration September 28, 2035 Stock options

Options vested 25% Vested on September 29, 2025

Options remaining to vest 75% Vest in 1/12 installments quarterly, subject to continued service

Key Terms

restricted stock unit ("RSU"), contingent right, vested and unvested stock options, vesting date

4 terms

restricted stock unit ("RSU") financial

"Each restricted stock unit ("RSU") represents a contingent right"

contingent right financial

"contingent right to receive one (1) share"

vested and unvested stock options financial

"90,000 vested and unvested stock options"

vesting date financial

"continued service through each such vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CARL shares and options did Jennifer Kamocsay report?

Jennifer Kamocsay, Carlsmed's Chief Legal Officer, reported direct holdings of 56,222 common shares and options covering 90,000 common shares as of September 24, 2026. The options have a $13.45 exercise price and expire September 28, 2035.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/30/2026 - 07:51 PM Accepted by SEC EDGAR 09/30/2026 - 07:51 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kamocsay Jennifer

(Last) (First) (Middle)

C/O CARLSMED, INC.

1800 ASTON AVE, SUITE 100

(Street)

CARLSBAD CALIFORNIA 92008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/24/2026

3. Issuer Name and Ticker or Trading Symbol
CARLSMED, INC. [ CARL ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	56,222(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	09/28/2035	Common Stock	90,000	$13.45	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date, January 28, 2026, subject to the Reporting Person's continued service through each such vesting date.

2. Includes 90,000 vested and unvested stock options convertible into approximately 90,000 shares of the Issuer's Common Stock. 25% of the stock options vested upon the one year anniversary of the grant date, September 29, 2025, and the remaining 75% of the stock options will vest in 1/12th installments on a quarterly basis thereafter, subject to the Reporting Person's continued service through each such vesting date.

	/s/ Jennifer Kamocsay	09/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)